The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms

American Journal of Hematology

Volumn 88, Issue 5, 2013, Pages 355-358

  Tadmor, T ^a,b   Bejar, J ^a   Attias, D ^a   Mischenko, E ^a   Sabo, E ^b,c   Neufeld, G ^b   Vadasz, Z ^a,b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Rambam Health Care Campus ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN LYSINE 6 OXIDASE;

ARTICLE; BLOOD LEVEL; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; IN VITRO STUDY; MULTIGENE FAMILY; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE NEOPLASM; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTHEMIA;

AMINO ACID OXIDOREDUCTASES; BONE MARROW; COHORT STUDIES; FIBROSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; ISOENZYMES; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MYELOPROLIFERATIVE DISORDERS; NEOPLASM PROTEINS; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; PROTEIN-LYSINE 6-OXIDASE; RNA, MESSENGER; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84876713908     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23409     Document Type: Article

References (27)

1. Vannucchi AM, Guglielmelli P, Tefferi A. Advances in understanding and management of myeloproliferative neoplasms. CA Cancer J Clin 2009;59:171-191.
2. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2007;22:14-22.
3. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. In Edition J Clin Oncol 2005;23:8520-8530.
4. Abdel-Wahab OI, Levine RL. Primary myelofibrosis: Update on definition, pathogenesis, and treatment. Annu Rev Med 2009;60:233-245.
5. Mesa RA, Verstovsek S, Cervantes F, et al. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res 2007;31:737-740.
6. Jacobson R, Salo A, Fialkow P. Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 1978;51:189-194.
7. Castro-Malaspina H, Gay R, Jhanwar S, et al. Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood 1982;59:1046-1054.
8. Martyré M-C, Magdelenat H, Bryckaert M-C, et al. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 1991;77:80-86.
9. Kagan HM, Li W. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 2003;88:660-672.
10. Smith-Mungo LI, Kagan HM. Lysyl oxidase: Properties, regulation and multiple functions in biology. Matrix Biology 1998;16:387-398.
11. Akiri G, Sabo E, Dafni H, et al. Lysyl Oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res 2003;63:1657-1666.
12. Decitre M, Gleyzal C, Raccurt M, et al. Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. Lab Invest 1998;78:143-151.
13. Eliades A, Papadantonakis N, Bhupatiraju A, et al. Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem 2011;286:27630-27638.
14. Papadantonakis N, Matsuura S, Ravid K. Megakaryocyte pathology and bone marrow fibrosis:the lysyl oxidase connection. Blood 2012;120:1774-1781.
15. Thiele J, Kvasnicka H, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005;90: 1128-1132.
16. Cohen T, Gluzman-Poltorak Z, Brodzky A, et al. Neuroendocrine cells along the digestive tract express neuropilin-2. Biochem Biophys Res Commun 2001;284:395-403.
17. Tefferi A. JAK inhibitors for myeloproliferative neoplasms: Clarifying facts from myths. Blood 2012;119:2721-2730.
18. Lucero HA, Ravid K, Grimsby JL, et al. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J Biol Chem 2008;283:24103-24117.
19. Green RS, Lieb ME, Weintraub AS, et al. Identification of lysyl oxidase and other platelet-derived growth factor-inducible genes in vascular smooth muscle cells by differential screening. Lab Invest 1995;73:476-482.
20. Hong HH, Uzel MI, Duan C, et al. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest 1999;79:1655-1667.
21. Terui T, Niitsu Y, Mahara K, et al. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 1990;75:1540-1548.
22. Vannucchi AM, Bianchi L, Paoletti F, et al. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-β1 in the development of myelofibrosis. Blood 2005;105:3493-3501.
23. Centurione L, Di Baldassarre A, Zingariello M, et al. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood 2004;104:3573-3580.
24. Ponce CC, de Lourdes F, Ihara SS, et al. The relationship of the active and latent forms of TGF-beta1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis. Med Oncol 2012;29:2337-2344.
25. Kanapathipillai M, Mammoto A, Mammoto T, et al. Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. Nano Lett 2012;12:3213-3217.
26. Bais MV, Nugent MA, Stephens DN, et al. Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS ONE 2012;7:e31188.
27. Kagan HM. Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Tropica 2000;77:147-152.